Getinge, a Swedish healthcare company, will target significant growth in India by expanding its product portfolio across premium and mid-value segments. It aims to increase its ventilator market share from 30 percent to 45 percent within five years.
With over 2,000 installations in leading hospitals like Apollo and Fortis, the company focuses on critical care, cardiovascular, and life sciences. It will introduce new products including ventilators, sterilisers, operating lights, and operating tables, in a ventilator market, valued at Rs 820 crore, with the premium segment in India projected at Rs 37.3 crore in 2024.
This emphasises investment in innovative solutions, distribution networks, and advanced technologies, such as a breast and thyroid surgery imaging tool and a high-end operating table for premium facilities. The company is also expanding its reach to Tier-II and Tier-III hospitals, ensuring access to cutting-edge healthcare.
In addition to ventilators, Getinge will leverage the growing demand for sterile injectables and vaccines in India's pharmaceutical sector. The company anticipates 30-35 percent growth in this segment, driven by its focus on life sciences and sterile processing technologies.
This strategic expansion positions Getinge as a versatile player catering to diverse healthcare needs across India.
